Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-22 HENDERSON MICHAEL THOMAS Director Sale 10b5-1 −20,000 $100.00 $2.0M 68,606
2026-05-27 HENDERSON MICHAEL THOMAS Director Grant or award · Stock Option (Right to Buy) +8,026 8,026
2026-05-08 HENDERSON MICHAEL THOMAS Director Sale 10b5-1 −2,404 $72.57 $174K 166,202
2026-05-08 HENDERSON MICHAEL THOMAS Director Sale 10b5-1 −33,513 $73.72 $2.5M 132,689
2026-05-08 HENDERSON MICHAEL THOMAS Director Sale 10b5-1 −24,814 $74.76 $1.9M 107,875
2026-05-08 HENDERSON MICHAEL THOMAS Director Sale 10b5-1 −19,269 $75.35 $1.5M 88,606
2026-01-21 HENDERSON MICHAEL THOMAS Director Other acquisition +63,227 168,606
2025-05-29 HENDERSON MICHAEL THOMAS Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2025-01-10 HENDERSON MICHAEL THOMAS Director Other acquisition +105,379 105,379
2024-05-14 HENDERSON MICHAEL THOMAS Director Grant or award · Stock Option (Right to Buy) +11,323 11,323

Page 1 of 1 · 10 trades